China SXT Pharmaceuticals (SXTC) Change in Account Payables (2018 - 2025)
Historic Change in Account Payables for China SXT Pharmaceuticals (SXTC) over the last 8 years, with Q3 2025 value amounting to $530662.0.
- China SXT Pharmaceuticals' Change in Account Payables fell 6808.49% to $530662.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $530662.0, marking a year-over-year decrease of 6808.49%. This contributed to the annual value of $1.2 million for FY2025, which is 947.37% down from last year.
- China SXT Pharmaceuticals' Change in Account Payables amounted to $530662.0 in Q3 2025, which was down 6808.49% from $1.2 million recorded in Q1 2025.
- China SXT Pharmaceuticals' Change in Account Payables' 5-year high stood at $1.7 million during Q3 2024, with a 5-year trough of $530662.0 in Q3 2025.
- For the 5-year period, China SXT Pharmaceuticals' Change in Account Payables averaged around $1.3 million, with its median value being $1.4 million (2021).
- As far as peak fluctuations go, China SXT Pharmaceuticals' Change in Account Payables soared by 2636.12% in 2024, and later crashed by 6808.49% in 2025.
- Over the past 5 years, China SXT Pharmaceuticals' Change in Account Payables (Quarter) stood at $1.5 million in 2021, then rose by 4.6% to $1.6 million in 2022, then fell by 15.72% to $1.3 million in 2023, then rose by 26.36% to $1.7 million in 2024, then plummeted by 68.08% to $530662.0 in 2025.
- Its last three reported values are $530662.0 in Q3 2025, $1.2 million for Q1 2025, and $1.7 million during Q3 2024.